# HCQ in Resectable Localized Prostate Cancer

> **NCT06408298** · EARLY_PHASE1 · RECRUITING · sponsor: **Lionel.D.Lewis, MD** · enrollment: 20 (estimated)

## Conditions studied

- Resectable Localized Prostate Cancer

## Interventions

- **DRUG:** Hydroxychloroquine Sulfate 400Mg Tab
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06408298
- **Lead sponsor:** Lionel.D.Lewis, MD
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-06
- **Primary completion:** 2029-02
- **Final completion:** 2029-03
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-02-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06408298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06408298, "HCQ in Resectable Localized Prostate Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06408298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*